270 related articles for article (PubMed ID: 23760919)
1. Desmoid: the role of local therapy in an era of systemic options.
Walczak BE; Rose PS
Curr Treat Options Oncol; 2013 Sep; 14(3):465-73. PubMed ID: 23760919
[TBL] [Abstract][Full Text] [Related]
2. Aggressive fibromatosis in children: a changing approach.
Meazza C; Alaggio R; Ferrari A
Minerva Pediatr; 2011 Aug; 63(4):305-18. PubMed ID: 21909066
[TBL] [Abstract][Full Text] [Related]
3. Desmoid-type fibromatoses involving the brachial plexus: treatment options and assessment of c-KIT mutational status.
Seinfeld J; Kleinschmidt-Demasters BK; Tayal S; Lillehei KO
J Neurosurg; 2006 May; 104(5):749-56. PubMed ID: 16703880
[TBL] [Abstract][Full Text] [Related]
4. Desmoid tumors: need for an individualized approach.
de Bree E; Keus R; Melissas J; Tsiftsis D; van Coevorden F
Expert Rev Anticancer Ther; 2009 Apr; 9(4):525-35. PubMed ID: 19374605
[TBL] [Abstract][Full Text] [Related]
5. Desmoid tumors: clinical features and treatment options for advanced disease.
Kasper B; Ströbel P; Hohenberger P
Oncologist; 2011; 16(5):682-93. PubMed ID: 21478276
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis.
van Broekhoven DL; Verhoef C; Elias SG; Witkamp AJ; van Gorp JM; van Geel BA; Wijrdeman HK; van Dalen T
Br J Surg; 2013 Aug; 100(9):1214-9. PubMed ID: 23804156
[TBL] [Abstract][Full Text] [Related]
7. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
[TBL] [Abstract][Full Text] [Related]
8. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series.
Mullen JT; Delaney TF; Kobayashi WK; Szymonifka J; Yeap BY; Chen YL; Rosenberg AE; Harmon DC; Choy E; Yoon SS; Raskin KA; Petur Nielsen G; Hornicek FJ
Ann Surg Oncol; 2012 Dec; 19(13):4028-35. PubMed ID: 22965569
[TBL] [Abstract][Full Text] [Related]
9. Optimal therapy for desmoid tumors: current options and challenges for the future.
Al-Jazrawe M; Au M; Alman B
Expert Rev Anticancer Ther; 2015; 15(12):1443-58. PubMed ID: 26472625
[TBL] [Abstract][Full Text] [Related]
10. Desmoid tumor: from surgical extirpation to molecular dissection.
Lazar AJ; Hajibashi S; Lev D
Curr Opin Oncol; 2009 Jul; 21(4):352-9. PubMed ID: 19436199
[TBL] [Abstract][Full Text] [Related]
11. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
[TBL] [Abstract][Full Text] [Related]
12. Multimodality management of desmoid tumors: how important is a negative surgical margin?
Melis M; Zager JS; Sondak VK
J Surg Oncol; 2008 Dec; 98(8):594-602. PubMed ID: 19072851
[TBL] [Abstract][Full Text] [Related]
13. Intra-abdominal desmoid fibromatosis mimicking tumour recurrence after the operation: A case series.
Nam KH; Kim B
Malays J Pathol; 2023 Apr; 45(1):111-122. PubMed ID: 37119251
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan.
Nishida Y; Hamada S; Kawai A; Kunisada T; Ogose A; Matsumoto Y; Ae K; Toguchida J; Ozaki T; Hirakawa A; Motoi T; Sakai T; Kobayashi E; Gokita T; Okamoto T; Matsunobu T; Shimizu K; Koike H
Cancer Sci; 2020 Aug; 111(8):2935-2942. PubMed ID: 32539220
[TBL] [Abstract][Full Text] [Related]
15. The Role of Radiation Therapy for Symptomatic Desmoid Tumors.
Looi WS; Indelicato DJ; Rutenberg MS
Curr Treat Options Oncol; 2021 Mar; 22(4):34. PubMed ID: 33649873
[TBL] [Abstract][Full Text] [Related]
16. Intra-Abdominal and Abdominal Wall Desmoid Fibromatosis.
Howard JH; Pollock RE
Oncol Ther; 2016; 4(1):57-72. PubMed ID: 28261640
[TBL] [Abstract][Full Text] [Related]
17. PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors.
Newman ET; Lans J; Kim J; Ferrone M; Ready J; Schwab J; Raskin K; Calderon SL
Clin Orthop Relat Res; 2020 Mar; 478(3):563-577. PubMed ID: 31429829
[TBL] [Abstract][Full Text] [Related]
18. Chest-wall desmoid tumors: results of surgical intervention.
Abbas AE; Deschamps C; Cassivi SD; Nichols FC; Allen MS; Schleck CD; Pairolero PC
Ann Thorac Surg; 2004 Oct; 78(4):1219-23; discussion 1219-23. PubMed ID: 15464474
[TBL] [Abstract][Full Text] [Related]
19. Current management and recent progress in desmoid tumors.
Zhou MY; Bui NQ; Charville GW; Ghanouni P; Ganjoo KN
Cancer Treat Res Commun; 2022; 31():100562. PubMed ID: 35460976
[TBL] [Abstract][Full Text] [Related]
20. Recurrent desmoid tumor of the abdominal wall.
Toughrai I; Oufkir A; Laalim SA; Majdoub KI; Mazaz K
Pan Afr Med J; 2012; 13():60. PubMed ID: 23346274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
